From: A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients
Sense
Antisense
19 exon outer
AAATAATCAGTGTGATTCGTGGAG
GAGGCCAGTGCTGTCTCTAAGG
19 exon inner
GTGCATCGCTGGTAACATCC
TGTGGAGATGAGCAGGGTCT
21 exon outer
GCAGCGGGTTACATCTTCTTTC
CAGCTCTGGCTCACACTACCAG
21 exon inner
GCTCAGAGCCTGGCATGAA
CATCCTCCCCTGCATGTGT